Artelus – Healthcare Startup to Revolutionize Diabetic Related Retina Diagnostics.

Source

Asia Tech Daily

Key Highlights of this Interview

• Foundation and Mission

  • Founded in 2017, Artelus (Artificial Learning Systems) is an India-based startup.
  • Specializes in AI and deep learning technologies to develop diagnostic products for healthcare.
  • Mission: Apply deep learning technology to improve lives by enhancing early detection and treatment of various diseases.

• Impact and Reach

  • Operations across 286 locations.
  • Claimed to have saved over 5000 eyes in less than a year.
  • Products offer accurate computer-aided screening tools for early detection of diabetic retinopathy.

• Product Innovations

  • Sushruta: An early identification screening tool for diabetic retinopathy.
  • Hansanet: Grades retina image quality.
  • Nimi: Segments regions for lesions in diabetic retinopathy.
  • Future projects include validation and data gathering for TB, lung cancer, breast cancer, and multiple sclerosis.

• Technology and Accuracy

  • Utilizes deep learning algorithms modeled on the brain's neural system.
  • Products improve diagnostic accuracy and speed with each scan due to their learning capability.
  • Experiments showed a 96% detection accuracy rate at the UAE Innovation Month 2018.
  • Faster and more accurate than human scans.

• Global Presence

  • Headquarters in Bangalore, with additional centers in Illinois, USA, and Dubai.
  • Positive feedback from doctors at the Dubai Health Authority for integrating the technology.

• Broader Goals

  • Developing screening tools for TB, lung cancer, and breast cancer.
  • Aim to complement healthcare providers by improving detection, diagnosis, prevention, and treatment.
  • Focus on the social impact of technology by preventing potential damage through early detection.

• Industry and Market

  • AI-supported healthcare is projected to be a multi-million-dollar industry.
  • Expected to be one of the top five industries impacted by AI and deep learning integration.

• Social Significance

  • Nearly a billion diabetics globally, with one in three at risk of vision loss.
  • Artelus's products aim to help in early detection and prevention of diabetic retinopathy (DR).
  • High accuracy, cost-effectiveness, time savings, and wider accessibility are key benefits of AI in healthcare.

Main Interview

Artelus, an India based start-up founded in 201 by Pradeep Walia, developed and introduced a range of groundbreaking diagnostic products to help aid healthcare professionals to fight the loss of vision in diabetics. Spread across 286 locations, Artelus claims to have saved over 5000 eyes in less than a year. The name stands for Artificial Learning System, as the company integrates artificial intelligence and deep learning technologies, a learning system modeled on the brain neural system that learns from data, to develop their innovative products that keep getting better with each diagnosis. Their products provide accurate computer-aided screening tools and diagnostics for early detection of diabetic retinopathy, which can help prevent loss of vision.

The Artelus team is also involved in developing screening tools to help detect TB, lung cancer, and breast cancer at an early stage by leveraging deep learning algorithms for early detection. The company aims to increase and complement the healthcare providers accurate detection and diagnosis, prevention and faster treatment of these ailments through their pioneering products with the stated mission to apply deep learning technology to make a difference in the lives of billions of people.

Artelus aims to improve healthcare through AI products as it will improve accuracy and speed. Their screening tools aimed at early detection are programmed to get better with each scan owing to the learning ability of deep learning technology. This means that the products not only provide a more accurate diagnosis over time but also help save often and help reduce costs. However, it is the social aspect of using these technologies highly significant for the role in preempting potential damage through early detection and prevention.

The company describes itself as a deep learning healthcare company. AI supported Healthcare is estimated to be a multi-million dollars industry and is also slated to be one of the top five industries hugely affected by the development and integration of AI and deep learning technologies.

Artelus Products for Diabetic Retinopathy

Artelus has developed three AI and deep learning products that specialize in providing diagnostic solutions: Sushruta, an early identification screening tool; Hansanet, for grading retina image quality, and Nimi, for segmenting region for legions for diabetic retinopathy.
There are several more projects and solutions in the pipeline that include validation and data gathering for TB, lung cancer, and breast cancers, and multiple sclerosis.

Deep Learning Technology Will Help Doctors Save Vision of Millions

Artelus is based in Bangalore with centers in Illinois, USA, and Dubai. Artelus displayed their products early this year in the UAE Innovation Month, 2018, the largest such event, where experiments confirmed 96% accuracy in the detection rate of their screening tools, which were also faster than the human scan of the retina. Doctors at the Dubai Health Authority showed a positive inclination to incorporate the technology and saw it as a boon to help millions.

There are nearly a billion diabetics in the world with one in three likely to lose their vision. Artelus' visionary products will go a long way in helping early detection and prevention of DR. The high accuracy along with cost-effectiveness, time saved, and wider accessibility are strong reasons for the encouragement and growth of an AI supported healthcare industry.